Cambridge Investment Research Advisors, Inc. Inspire Medical Systems, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	SELL	$226.52 - $324.64 $51,193 - $73,368	-226 Reduced 17.13%	1,093 $355,000
Q1 2023 May 11, 2023	SELL	$229.06 - $278.01 $213,025 - $258,549	-930 Reduced 41.35%	1,319 $309,000
Q4 2022 Feb 08, 2023	BUY	$164.02 - $259.76 $134,496 - $213,003	820 Added 57.38%	2,249 $566,000
Q3 2022 Oct 17, 2022	BUY	$170.68 - $226.46 $53,081 - $70,429	311 Added 27.82%	1,429 $253,000
Q2 2022 Jul 13, 2022	BUY	$147.53 - $266.6 $10,917 - $19,728	74 Added 7.09%	1,118 $204,000
Q1 2022 May 12, 2022	SELL	$193.94 - $261.91 $58,375 - $78,834	-301 Reduced 22.38%	1,044 $267,000
Q4 2021 Feb 03, 2022	BUY	$207.57 - $280.17 $279,181 - $376,828	1,345 New	1,345 $309,000

Others Institutions Holding INSP

# of Institutions

397

Shares Held

27.5M

Call Options Held

519K

Put Options Held

590K

View Full List

About Inspire Medical Systems, Inc.

Ticker INSP
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,788,600
Market Cap $5.43B
Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...

More about INSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account